ID: ALA1161997

Max Phase: Preclinical

Molecular Formula: C3H8NO6P

Molecular Weight: 185.07

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(CC(O)P(=O)(O)O)NO

Standard InChI:  InChI=1S/C3H8NO6P/c5-2(4-7)1-3(6)11(8,9)10/h3,6-7H,1H2,(H,4,5)(H2,8,9,10)

Standard InChI Key:  IXTLPXIJEWXYCB-UHFFFAOYSA-N

Associated Targets(Human)

Triosephosphate isomerase 22 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 185.07Molecular Weight (Monoisotopic): 185.0089AlogP: -1.62#Rotatable Bonds: 3
Polar Surface Area: 127.09Molecular Species: ACIDHBA: 4HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.29CX Basic pKa: CX LogP: -2.75CX LogD: -5.20
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.20Np Likeness Score: 0.43

References

1. Fonvielle M, Therisod H, Hemery M, Therisod M..  (2007)  New competitive inhibitors of cytosolic (NADH-dependent) rabbit muscle glycerophosphate dehydrogenase.,  17  (2): [PMID:17088060] [10.1016/j.bmcl.2006.10.030]

Source